136 related articles for article (PubMed ID: 25371597)
1. Elevated plasma stromal-cell-derived factor-1 protein levels correlate with severity in patients with community-acquired pneumonia.
Tsai PK; Hsieh MJ; Wang HL; Chou MC; Yang SF; Yeh CB
Dis Markers; 2014; 2014():829706. PubMed ID: 25371597
[TBL] [Abstract][Full Text] [Related]
2. Plasma Monocyte Chemoattractant Protein-1 Level as a Predictor of the Severity of Community-Acquired Pneumonia.
Yong KK; Chang JH; Chien MH; Tsao SM; Yu MC; Bai KJ; Tsao TC; Yang SF
Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26840299
[TBL] [Abstract][Full Text] [Related]
3. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
[TBL] [Abstract][Full Text] [Related]
4. Plasma endothelial cell-specific molecule-1 (ESM-1) in management of community-acquired pneumonia.
Kao SJ; Chuang CY; Tang CH; Lin CH; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2014 Mar; 52(3):445-51. PubMed ID: 24108208
[TBL] [Abstract][Full Text] [Related]
5. Significant elevation of plasma cathepsin B and cystatin C in patients with community-acquired pneumonia.
Lee YT; Chen SC; Shyu LY; Lee MC; Wu TC; Tsao SM; Yang SF
Clin Chim Acta; 2012 Mar; 413(5-6):630-5. PubMed ID: 22209964
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of soluble intercellular adhesion molecule-1 as a biomarker for disease severity of patients with community-acquired pneumonia.
Chang PY; Tsao SM; Chang JH; Chien MH; Hung WY; Huang YW; Yang SF
Clin Chim Acta; 2016 Dec; 463():174-180. PubMed ID: 27983998
[TBL] [Abstract][Full Text] [Related]
7. Utility of Plasma Osteopontin Levels in Management of Community-Acquired Pneumonia.
Chang JH; Hung WY; Bai KJ; Yang SF; Chien MH
Int J Med Sci; 2016; 13(9):673-9. PubMed ID: 27647996
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of plasma neutrophil gelatinase-associated lipocalin concentration for predicting the severity and mortality of patients with community-acquired pneumonia.
Kim JW; Hong DY; Lee KR; Kim SY; Baek KJ; Park SO
Clin Chim Acta; 2016 Nov; 462():140-145. PubMed ID: 27662812
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients.
Wang HL; Hsiao PC; Tsai HT; Yeh CB; Yang SF
Int J Mol Sci; 2013 Nov; 14(11):22817-25. PubMed ID: 24256818
[TBL] [Abstract][Full Text] [Related]
10. Circulating level of lipocalin 2 as a predictor of severity in patients with community-acquired pneumonia.
Yeh YH; Chang JL; Hsiao PC; Tsao SM; Lin CH; Kao SJ; Chou MC; Yang SF; Chien MH
J Clin Lab Anal; 2013 Jul; 27(4):253-60. PubMed ID: 23852780
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of soluble Axl correlate with severity of community-acquired pneumonia.
Ko CP; Yu YL; Hsiao PC; Yang SF; Yeh CB
Mol Med Rep; 2014 Apr; 9(4):1400-4. PubMed ID: 24503651
[TBL] [Abstract][Full Text] [Related]
12. The circulating level of MMP-9 and its ratio to TIMP-1 as a predictor of severity in patients with community-acquired pneumonia.
Chiang TY; Yu YL; Lin CW; Tsao SM; Yang SF; Yeh CB
Clin Chim Acta; 2013 Sep; 424():261-6. PubMed ID: 23792071
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma matrix metalloproteinase-9 protein and its gene polymorphism in patients with community-acquired pneumonia.
Chiang TY; Shyu LY; Tsao TC; Chien MH; Tsao SM; Lee YT; Yang SF
Clin Chem Lab Med; 2011 Nov; 50(3):449-54. PubMed ID: 22107133
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.
Liu S; He LR; Wang W; Wang GH; He ZY
Respir Care; 2013 Apr; 58(4):655-61. PubMed ID: 23051183
[TBL] [Abstract][Full Text] [Related]
15. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.
Wu HP; Chen CK; Chung K; Jiang BY; Yu TJ; Chuang DY
J Formos Med Assoc; 2009 Jan; 108(1):20-7. PubMed ID: 19181604
[TBL] [Abstract][Full Text] [Related]
16. Endogenous carboxyhemoglobin concentrations in the assessment of severity in patients with community-acquired pneumonia.
Corbacioglu SK; Kilicaslan I; Bildik F; Guleryuz A; Bekgoz B; Ozel A; Keles A; Demircan A
Am J Emerg Med; 2013 Mar; 31(3):520-3. PubMed ID: 23219346
[TBL] [Abstract][Full Text] [Related]
17. CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS.
Richards G; Levy H; Laterre PF; Feldman C; Woodward B; Bates BM; Qualy RL
J Intensive Care Med; 2011; 26(1):34-40. PubMed ID: 21341394
[TBL] [Abstract][Full Text] [Related]
18. Associations of Serum S100A12 With Severity and Prognosis in Patients With Community-Acquired Pneumonia: A Prospective Cohort Study.
Jiang X; Huang CM; Feng CM; Xu Z; Fu L; Wang XM
Front Immunol; 2021; 12():714026. PubMed ID: 34745092
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
Chen Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
[TBL] [Abstract][Full Text] [Related]
20. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule.
Kanwar M; Brar N; Khatib R; Fakih MG
Chest; 2007 Jun; 131(6):1865-9. PubMed ID: 17400668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
